| PDF - Veröffentlichte Version (819kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-443760
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.44376
Zusammenfassung
Background: This controlled clinical study aimed to investigate the impact of obesity on plasma and tissue pharmacokinetics of meropenem. Methods: Obese (body mass index (BMI) >= 35 kg/m(2)) and age-/sex-matched nonobese (18.5 kg/m(2) >= BMI <= 30 kg/m(2)) surgical patients received a short-term infusion of 1000-mg meropenem. Concentrations were determined via high performance liquid ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik